甘油三酯-葡萄糖体重指数与原发性高血压患者靶器官损害的关联:一项回顾性队列研究。

IF 2.5 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Ahmed Bashir, Muhammad Bashir, Muhammad Aman Rizwan
{"title":"甘油三酯-葡萄糖体重指数与原发性高血压患者靶器官损害的关联:一项回顾性队列研究。","authors":"Ahmed Bashir,&nbsp;Muhammad Bashir,&nbsp;Muhammad Aman Rizwan","doi":"10.1111/jch.70158","DOIUrl":null,"url":null,"abstract":"<p>To the Editor,</p><p>We have read the article “Association of Triglyceride–Glucose Body Mass Index with Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study” by Huang et al. [<span>1</span>] with great interest. We would like to acknowledge the author's rigorous work in this important area that will be appreciated by the readers. We agree with their final conclusion that TyG-BMI is a simple and inexpensive index that measures obesity and incorporates insulin resistance, and that having prognostic ability similar to traditional risk factor models may be helpful in identifying and monitoring children at risk for future poor health outcomes.</p><p>We do, however, think that a couple of additional points could potentially strengthen the conclusion of the article.</p><p>First, the method of a retrospective cohort study [<span>2</span>] has inherent biases; we need to consider including selection bias and residual confounding. Although the authors describe that multivariable adjustments were made for baseline characteristics, it will be challenging to control for the dynamic nature of the baseline factors, like medication compliance, lifestyle changes, or clinical management over 23 months of follow-up. As with all unmeasured variables, they may have effects on both TyG-BMI and the progression of target organ damage, which limits conclusions of causation. Large-scale prospective studies of long duration need to validate these findings.</p><p>Second, even though Huang et al. [<span>1</span>] used TyG-BMI as a surrogate measure for insulin resistance (IR), there are concerns over the generalizability and diagnostic accuracy of the measure. A recent systematic review concluded that the hyperinsulinemic-euglycemic clamp remains the gold standard of assessing IR. While the TyG index had variable performance across different populations, it lacks standardized cut-offs [<span>3</span>]. The absence of the gold-standard assessment in the study prevents us from identifying the true diagnostic accuracy of the TyG-BMI. More importantly, a singular, simplified index may overlook the complexities and relationships between IR, hypertension, and the progression of target organ damage, which could limit its clinical utility across different groups of patients.</p><p>Third, metabolic markers, including fasting glucose and triglycerides, which are the fundamental elements of the TyG-BMI calculation, were assessed only once at baseline and do not necessarily reflect long-term changes or variation, which makes them more prone to misclassification risk. For example, one study that investigated the cardiovascular risk with longitudinal comparisons demonstrated that it is useful to repeat key measurements in people with high blood pressure [<span>4</span>]. Future studies should attempt to compare various measurements in order to establish if there is any relationship between multiple parameters with the development of cardiovascular-related outcomes.</p><p>Fourth, the study did not include key anthropometric indicators such as BMI, waist circumference, smoking, and drinking, as these factors likely contribute to determining the association between TyG-BMI and organ damage. Another study graciously pointed out how lack of smoking, drinking, and anthropometric data would also reduce the quality of the research [<span>5</span>]. Future studies should include complete patient characteristics to improve accuracy and minimize residual confounding.</p><p>In conclusion, Huang et al. [<span>1</span>] provided much value regarding the prognostic utility of TyG-BMI in hypertension. Nonetheless, the incorporation of retrospective design with potential unmeasured confounders, use of single baseline metabolic marker assessments, absence of gold-standard measures for insulin resistance, short follow-up period, and incomplete anthropometric and lifestyle data in future larger prospective studies with extended follow-up and more accurate data collection would yield more robust results and help establish the clinical utility and prognostic validity of TyG-BMI.</p><p><b>Ahmed Bashir</b>: conceptualization, writing – original draft, and literature search. <b>Muhammad Bashir</b>: writing – original draft, writing – review and editing, and validation. <b>Muhammad Aman Rizwan</b>: writing – original draft, supervision, project administration, and final approval. All authors agree to be accountable for all aspects of the work.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":"27 9","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.70158","citationCount":"0","resultStr":"{\"title\":\"Association of Triglyceride–Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study\",\"authors\":\"Ahmed Bashir,&nbsp;Muhammad Bashir,&nbsp;Muhammad Aman Rizwan\",\"doi\":\"10.1111/jch.70158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>To the Editor,</p><p>We have read the article “Association of Triglyceride–Glucose Body Mass Index with Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study” by Huang et al. [<span>1</span>] with great interest. We would like to acknowledge the author's rigorous work in this important area that will be appreciated by the readers. We agree with their final conclusion that TyG-BMI is a simple and inexpensive index that measures obesity and incorporates insulin resistance, and that having prognostic ability similar to traditional risk factor models may be helpful in identifying and monitoring children at risk for future poor health outcomes.</p><p>We do, however, think that a couple of additional points could potentially strengthen the conclusion of the article.</p><p>First, the method of a retrospective cohort study [<span>2</span>] has inherent biases; we need to consider including selection bias and residual confounding. Although the authors describe that multivariable adjustments were made for baseline characteristics, it will be challenging to control for the dynamic nature of the baseline factors, like medication compliance, lifestyle changes, or clinical management over 23 months of follow-up. As with all unmeasured variables, they may have effects on both TyG-BMI and the progression of target organ damage, which limits conclusions of causation. Large-scale prospective studies of long duration need to validate these findings.</p><p>Second, even though Huang et al. [<span>1</span>] used TyG-BMI as a surrogate measure for insulin resistance (IR), there are concerns over the generalizability and diagnostic accuracy of the measure. A recent systematic review concluded that the hyperinsulinemic-euglycemic clamp remains the gold standard of assessing IR. While the TyG index had variable performance across different populations, it lacks standardized cut-offs [<span>3</span>]. The absence of the gold-standard assessment in the study prevents us from identifying the true diagnostic accuracy of the TyG-BMI. More importantly, a singular, simplified index may overlook the complexities and relationships between IR, hypertension, and the progression of target organ damage, which could limit its clinical utility across different groups of patients.</p><p>Third, metabolic markers, including fasting glucose and triglycerides, which are the fundamental elements of the TyG-BMI calculation, were assessed only once at baseline and do not necessarily reflect long-term changes or variation, which makes them more prone to misclassification risk. For example, one study that investigated the cardiovascular risk with longitudinal comparisons demonstrated that it is useful to repeat key measurements in people with high blood pressure [<span>4</span>]. Future studies should attempt to compare various measurements in order to establish if there is any relationship between multiple parameters with the development of cardiovascular-related outcomes.</p><p>Fourth, the study did not include key anthropometric indicators such as BMI, waist circumference, smoking, and drinking, as these factors likely contribute to determining the association between TyG-BMI and organ damage. Another study graciously pointed out how lack of smoking, drinking, and anthropometric data would also reduce the quality of the research [<span>5</span>]. Future studies should include complete patient characteristics to improve accuracy and minimize residual confounding.</p><p>In conclusion, Huang et al. [<span>1</span>] provided much value regarding the prognostic utility of TyG-BMI in hypertension. Nonetheless, the incorporation of retrospective design with potential unmeasured confounders, use of single baseline metabolic marker assessments, absence of gold-standard measures for insulin resistance, short follow-up period, and incomplete anthropometric and lifestyle data in future larger prospective studies with extended follow-up and more accurate data collection would yield more robust results and help establish the clinical utility and prognostic validity of TyG-BMI.</p><p><b>Ahmed Bashir</b>: conceptualization, writing – original draft, and literature search. <b>Muhammad Bashir</b>: writing – original draft, writing – review and editing, and validation. <b>Muhammad Aman Rizwan</b>: writing – original draft, supervision, project administration, and final approval. All authors agree to be accountable for all aspects of the work.</p><p>The authors declare no conflicts of interest.</p>\",\"PeriodicalId\":50237,\"journal\":{\"name\":\"Journal of Clinical Hypertension\",\"volume\":\"27 9\",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.70158\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jch.70158\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.70158","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

致编辑:我们饶有兴趣地阅读了Huang等人的文章《甘油三酯-葡萄糖体重指数与原发性高血压患者靶器官损伤的关联:一项回顾性队列研究》。我们要感谢作者在这一重要领域所做的严谨工作,这将受到读者的赞赏。我们同意他们的最终结论,即TyG-BMI是一种简单而廉价的衡量肥胖和胰岛素抵抗的指数,并且具有与传统风险因素模型相似的预测能力,可能有助于识别和监测未来有不良健康结果风险的儿童。然而,我们确实认为,一些额外的观点可能会加强文章的结论。首先,回顾性队列研究的方法存在固有偏差;我们需要考虑包括选择偏差和残留混淆。尽管作者描述了对基线特征进行了多变量调整,但要控制基线因素的动态性质将具有挑战性,如药物依从性、生活方式改变或23个月随访的临床管理。与所有未测量的变量一样,它们可能对TyG-BMI和靶器官损伤的进展都有影响,这限制了因果关系的结论。需要长期的大规模前瞻性研究来验证这些发现。其次,尽管Huang等人使用TyG-BMI作为胰岛素抵抗(IR)的替代指标,但仍存在对该指标的普遍性和诊断准确性的担忧。最近的一项系统综述得出结论,高胰岛素-血糖钳仍然是评估IR的金标准。虽然TyG指数在不同人群中的表现不尽相同,但它缺乏标准化的临界值。研究中缺乏金标准评估,使我们无法确定TyG-BMI的真正诊断准确性。更重要的是,单一、简化的指标可能会忽略IR、高血压和靶器官损伤进展之间的复杂性和关系,这可能会限制其在不同患者群体中的临床应用。第三,代谢指标,包括空腹血糖和甘油三酯,这是TyG-BMI计算的基本要素,仅在基线时评估一次,并不一定反映长期变化或变异,这使得它们更容易出现错误分类的风险。例如,一项通过纵向比较调查心血管风险的研究表明,对高血压患者重复关键测量是有用的。未来的研究应该尝试比较各种测量,以确定多个参数与心血管相关结局的发展之间是否存在任何关系。第四,该研究没有包括关键的人体测量指标,如BMI、腰围、吸烟和饮酒,因为这些因素可能有助于确定TyG-BMI与器官损伤之间的关系。另一项研究优雅地指出,缺乏吸烟、饮酒和人体测量数据也会降低研究结果的质量。未来的研究应包括完整的患者特征,以提高准确性和减少残留的混杂。综上所述,Huang等人提供了TyG-BMI在高血压预后方面的重要价值。尽管如此,在未来更大规模的前瞻性研究中,结合回顾性设计和潜在的未测量混杂因素,使用单一基线代谢标志物评估,缺乏胰岛素抵抗的金标准测量,随访时间短,以及不完整的人体测量和生活方式数据,延长随访时间和更准确的数据收集,将产生更可靠的结果,并有助于建立TyG-BMI的临床实用性和预后有效性。艾哈迈德·巴希尔:概念化,写作原稿,文献检索。穆罕默德·巴希尔:写作-原稿,写作-审查和编辑,和验证。穆罕默德·阿曼·里兹万:写作——初稿、监督、项目管理、最终审批。所有作者同意对工作的各个方面负责。作者声明无利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Association of Triglyceride–Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study

Association of Triglyceride–Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study

To the Editor,

We have read the article “Association of Triglyceride–Glucose Body Mass Index with Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study” by Huang et al. [1] with great interest. We would like to acknowledge the author's rigorous work in this important area that will be appreciated by the readers. We agree with their final conclusion that TyG-BMI is a simple and inexpensive index that measures obesity and incorporates insulin resistance, and that having prognostic ability similar to traditional risk factor models may be helpful in identifying and monitoring children at risk for future poor health outcomes.

We do, however, think that a couple of additional points could potentially strengthen the conclusion of the article.

First, the method of a retrospective cohort study [2] has inherent biases; we need to consider including selection bias and residual confounding. Although the authors describe that multivariable adjustments were made for baseline characteristics, it will be challenging to control for the dynamic nature of the baseline factors, like medication compliance, lifestyle changes, or clinical management over 23 months of follow-up. As with all unmeasured variables, they may have effects on both TyG-BMI and the progression of target organ damage, which limits conclusions of causation. Large-scale prospective studies of long duration need to validate these findings.

Second, even though Huang et al. [1] used TyG-BMI as a surrogate measure for insulin resistance (IR), there are concerns over the generalizability and diagnostic accuracy of the measure. A recent systematic review concluded that the hyperinsulinemic-euglycemic clamp remains the gold standard of assessing IR. While the TyG index had variable performance across different populations, it lacks standardized cut-offs [3]. The absence of the gold-standard assessment in the study prevents us from identifying the true diagnostic accuracy of the TyG-BMI. More importantly, a singular, simplified index may overlook the complexities and relationships between IR, hypertension, and the progression of target organ damage, which could limit its clinical utility across different groups of patients.

Third, metabolic markers, including fasting glucose and triglycerides, which are the fundamental elements of the TyG-BMI calculation, were assessed only once at baseline and do not necessarily reflect long-term changes or variation, which makes them more prone to misclassification risk. For example, one study that investigated the cardiovascular risk with longitudinal comparisons demonstrated that it is useful to repeat key measurements in people with high blood pressure [4]. Future studies should attempt to compare various measurements in order to establish if there is any relationship between multiple parameters with the development of cardiovascular-related outcomes.

Fourth, the study did not include key anthropometric indicators such as BMI, waist circumference, smoking, and drinking, as these factors likely contribute to determining the association between TyG-BMI and organ damage. Another study graciously pointed out how lack of smoking, drinking, and anthropometric data would also reduce the quality of the research [5]. Future studies should include complete patient characteristics to improve accuracy and minimize residual confounding.

In conclusion, Huang et al. [1] provided much value regarding the prognostic utility of TyG-BMI in hypertension. Nonetheless, the incorporation of retrospective design with potential unmeasured confounders, use of single baseline metabolic marker assessments, absence of gold-standard measures for insulin resistance, short follow-up period, and incomplete anthropometric and lifestyle data in future larger prospective studies with extended follow-up and more accurate data collection would yield more robust results and help establish the clinical utility and prognostic validity of TyG-BMI.

Ahmed Bashir: conceptualization, writing – original draft, and literature search. Muhammad Bashir: writing – original draft, writing – review and editing, and validation. Muhammad Aman Rizwan: writing – original draft, supervision, project administration, and final approval. All authors agree to be accountable for all aspects of the work.

The authors declare no conflicts of interest.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Hypertension
Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-
CiteScore
5.80
自引率
7.10%
发文量
191
审稿时长
4-8 weeks
期刊介绍: The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信